Meiko Nishimura
Ariake, 1358550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 02, 2026
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).
Journal: Breast cancer research and treatment
Published: March 30, 2026
Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.
Journal: Breast disease
Published: December 05, 2025
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Journal: Breast cancer (Tokyo, Japan)
Published: September 17, 2024
Desire for pregnancy and fertility preservation in young patients with breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: March 21, 2024
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial.
Journal: Frontiers in oncology
Published: May 04, 2023
Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
Journal: Anticancer research
Published: January 06, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: October 25, 2021
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Journal: International journal of hematology
Published: September 06, 2021
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.
Journal: International journal of clinical oncology
Published: January 22, 2021
Last Updated: 09/26/2026